Circular 581: simplification of the reporting system on experimental medicines

Circular 581 of 27/10/2011 gives to holders of authorisation "30/06/2004" information about the new system in place to report any activity of manufacture, importation, distribution or storage of medicines used in experimental clinical trials. This simplified system of post reporting of these activities will apply from 1st January 2012.

See other languages.

Contact : IMP-declarations@afmps.be

Last updated on 30/11/2011